Translate Bio
We are pioneering the translation of mRNA therapeutics into transformative medicines.
Recent News
Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Translate Bio Announces Timing of Interim Results from mRNA Therapeutic Clinical Trial in Patients with Cystic Fibrosis; Data Expected in Early Q2 2021